A further example of the low frequency antigen Pta

Area of Science:

• Hematology
• Immunology
• Genetics

Background:

• The Pt(a+) blood group system represents a rare inherited red blood cell antigen.
• Understanding the biochemical properties of red cell antigens is crucial for transfusion medicine and understanding blood group genetics.

Purpose of the Study:

• To describe the third identified family with the Pt(a+) blood group.
• To investigate the biochemical characteristics of the Pt(a+) red cell antigen, specifically its susceptibility to enzymatic and chemical treatments.

Main Methods:

• Characterization of the third Pt(a+) family.
• Treatment of red blood cells expressing the Pt(a+) antigen with proteolytic enzymes.
• Treatment of red blood cells expressing the Pt(a+) antigen with neuraminidase.
• Treatment of red blood cells expressing the Pt(a+) antigen with 2-aminoethylisothiouronium bromide.

Main Results:

• The Pt(a+) red cell antigen was confirmed in the third described family.
• Treatment with proteolytic enzymes resulted in the denaturation of the Pt(a+) red cell antigen.
• Neuraminidase treatment did not affect the Pt(a+) red cell antigen.
• 2-aminoethylisothiouronium bromide treatment did not alter the Pt(a+) red cell antigen.

Conclusions:

• The Pt(a+) red cell antigen exhibits specific sensitivity to proteolytic enzymes, indicating a protein-based structure.
• The antigen's resistance to neuraminidase and 2-aminoethylisothiouronium bromide suggests it is not primarily composed of sialic acid or modified by these agents.